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Abstract 30 
This study set out to analyze questions about type 2 diabetes mellitus (T2DM) from patients and 31 
the public. The aim was to better understand people’s information needs by starting with what 32 
they do not know, discovered through their own questions, rather than starting with what we 33 
know about T2DM and subsequently finding ways to communicate that information to people 34 
affected by or at risk of the disease. One hundred and sixty-four questions were collected from 35 
120 patients attending outpatient diabetes clinics and 300 questions from 100 members of the 36 
public through the Amazon Mechanical Turk crowdsourcing platform. Twenty-three general and 37 
diabetes-specific topics and five phases of disease progression were identified; these were used 38 
to manually categorize the questions. Analyses were performed to determine which topics, if 39 
any, were significant predictors of a question’s being asked by a patient or the public, and 40 
similarly for questions from a woman or a man. Further analysis identified  the individual topics 41 
that were assigned significantly more often to the crowdsourced or clinic questions. These  were 42 
CAUSES (CI: [-0.07, -0.03], p < .001), RISK FACTORS ([-0.08, -0.03], p < .001), PREVENTION ([-43 
0.06, -0.02], p < .001), DIAGNOSIS ([-0.05, -0.02], p < .001), and DISTRIBUTION OF A DISEASE IN 44 
A POPULATION ([-0.05 ,-0.01], p = .0016) for the crowdsourced questions and TREATMENT ([0.03, 45 
0.01], p = .0019), DISEASE COMPLICATIONS ([0.02, 0.07], p < .001), and PSYCHOSOCIAL ([0.05, 46 
0.1], p < .001) for the clinic questions.  No highly significant gender-specific topics emerged in 47 
our study, but questions about WEIGHT were more likely to come from women and 48 
PSYCHOSOCIAL questions from men. There were significantly more crowdsourced questions 49 
about the time PRIOR TO ANY DIAGNOSIS ([(-0.11, -0.04], p = .0013) and significantly more clinic 50 
questions about HEALTH MAINTENANCE AND PREVENTION after diagnosis ([0.07. 0.17], p < .001).  51 
A descriptive analysis pointed to the value provided by the specificity of questions, their 52 
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potential to disclose emotions behind questions, and the as-yet unrecognized information needs 53 
they can reveal. Large-scale collection of questions from patients across the spectrum of T2DM 54 
progression and from the public – a significant percentage of whom are likely to be as yet 55 
undiagnosed – is expected to yield further valuable insights.   56 
 57 
Introduction 58 
Diabetes is a major health problem worldwide. The prevalence of global, age-standardized diabetes 59 
is 9% in men and 7.9% in women, with the number having risen around the globe from 108 million 60 
in 1980 to 422 million in 2014 [1]. Type 2 diabetes mellitus (T2DM) is a main driver of the 61 
increase, accounting for approximately 90% of all diabetes cases [2-4]. Diabetes is a complex 62 
condition and people with diabetes have a diverse range of information needs [5-8]. Large-scale 63 
investigations such as the DAWN studies on the attitudes, wishes and needs of patients and 64 
caregivers [9, 10] have told us much, but research to date has paid little attention to exploring the 65 
information needs of patients as expressed in the questions they have about diabetes. Questions 66 
convey information needs in the patient’s own voice and permit the individual and subjective 67 
experience of illness to be captured [11]. To our knowledge, no-one to date has investigated on a 68 
large scale what T2DM patients want to know at different stages of diagnosis and treatment by 69 
asking them directly what their questions are, nor have questions from the public been solicited 70 
and examined. 71 
 Our study concerns a new way of thinking about patient information needs in diabetes, 72 
starting not with what we know about T2DM and finding ways to communicate that information 73 
to patients but starting with what patients do not know, discovered through their own questions. 74 
Soliciting, and then responding, to patient questions on a large scale has the potential to create a 75 
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new information resource for T2DM, both in terms of content and organization. A questions-76 
based approach to patient knowledge is distinct from active information seeking through which 77 
the patient searches extant information resources [5], and it is distinct from passive information 78 
receipt in which the patient is exposed either accidentally or deliberately to extant information 79 
resources [12]. A questions-based approach has the potential to create a dynamic, continually 80 
updated resource that will capture patient information needs as they evolve over time.   81 
 It is estimated that more than half of American adults have either T2DM or prediabetes 82 
(as measured by blood sugar levels or determined by diagnosis) and of those more than one-third 83 
are unaware they have the disease [13]. Consequently, it is crucial that we understand the 84 
information needs and voice of those who do not have diabetes, or do not know they have 85 
diabetes, but still have questions whether out of curiosity or concern for themselves or a loved 86 
one. In this paper, we report on the first stage of our work soliciting questions directly from both 87 
patients and the general public and analyzing the questions to see what they reveal. 88 
 Questions play a vital role in health care.  Patient questions foster good communication 89 
with health professionals, resulting in better care and the right care at the right time [14-17]. 90 
However, poor bi-directional flow of information between the diabetes health professional and the 91 
patient has been documented. Discrepancies have also been noted between information provided 92 
by health care providers and what patients with diabetes need [18].  Patients often cannot get as 93 
much detail as they need during office visits [19].Time constraints, whether actual or perceived, 94 
prevent some patients from asking questions during the consultation [5, 20]. Patients also find it 95 
difficult to retain much of what they have been told by a health professional, and what they do 96 
remember is incorrect almost half the time [21-23].   97 
 Clinical information needs have been extensively studied by collecting questions from 98 
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physicians and analyzing them [24-44]. For patients and the general population, the situation is 99 
very different. Only recently have their health questions been studied in any depth [45-51], with 100 
few studies, to our knowledge, focusing on diabetes or investigating differences between questions 101 
from patients and those not in a patient setting.  Our recent study has shown that available online 102 
sources of information do not provide answers to patient questions about diabetes and that there is 103 
an urgent need to better understand these information needs [52]. In this study, therefore, we set 104 
out to collect and investigate questions about diabetes from two sources, namely, patients attending 105 
a diabetes clinic and the public through crowdsourcing. We hypothesized that an analysis of the 106 
questions in terms of the topics they cover and the phases of disease progression they concern 107 
would provide important insights, potentially also revealing differences in information needs 108 
between patients and those outside the patient setting, who may or may not have diabetes or may 109 
be unaware they have the disease. 110 
 111 
Methods 112 
Ethics statement 113 
This study makes secondary use of anonymized data. A prior service evaluation had been 114 
approved within the South Eastern Health and Social Care Trust, Northern Ireland, to assess 115 
patient information needs by approaching patients attending the diabetes clinic and asking them 116 
to provide questions. They were free to refuse if they wished to. No participant consent was 117 
needed for the service evaluation and none was sought. Questions were recorded on a sheet 118 
provided to each patient if interested, with no identifiers such as clinic time, clinician or personal 119 
information collected.  No ethics committee approval was needed for our secondary analysis of 120 
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the collected questions. This practice conforms to the guidelines of the Health Research 121 
Authority of the UK National Health Service and current UK legislative and good practice 122 
arrangements. The authors had no direct contact with the participants and there were no minors 123 
among the participants. 124 
Question collection 125 
As part of a prior service evaluation, all patients attending the weekly diabetes outpatient clinic at 126 
the Ulster Hospital in Northern Ireland during February to April, 2014 had been invited to submit 127 
questions by responding to the following: What are the one or two most pressing questions about 128 
your diabetes that you would like answered? Patients were provided with a blank page to record 129 
their questions and questions from the same individual were marked as such.  130 
We obtained additional questions using the crowdsourcing platform of Amazon 131 
Mechanical Turk (AMT). Crowdsourcing has become an important part of many clinical studies 132 
[53], with new platforms emerging to meet the particular requirements of research [54]. One 133 
hundred AMT participants were asked to each enter three questions s/he had about diabetes. 134 
Each participant was asked to specify age, sex/gender and if s/he had a diagnosis of type 2 or 135 
type 1 diabetes, or a diagnosis of diabetes but did not know the type, and if s/he had a friend or 136 
family member with a diagnosis of type 2, type 1 or unknown type. Crowdsourced question 137 
collection took place on July 8
th
 -11
th
, 2015.  138 
The clinic and crowdsourced question corpora are given in S1 File and S2 File. All 139 
questions are presented as written by the participants, with spelling and punctuation intact. 140 
Categorization by topic and phase 141 
Question content was determined through fine-grained manual categorization of the topics and the 142 
phases of diabetes progression the question referred to. Such detailed assessment of need is part of 143 
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the move towards better disease management through understanding the likely information needs 144 
of different subgroups of people at different phases of the disease, at the onset of diabetes, for 145 
example, or later when a new complication has developed.  146 
An initial set of 13 topics, based on known concerns of patients with diabetes [5-10, 55-147 
57] and our prior work on consumer questions [16], was compiled and used to conduct a 148 
preliminary categorization of the crowdsourced questions. This undertaking led to an expanded 149 
set of 23 topics for use in this study.  We additionally compiled a five-part patient-oriented 150 
classification of the phases of T2DM drawing on prior work and our clinical experience [58-151 
67].  152 
 Two researchers independently categorized each question by topic and phase. A question 153 
could fall under more than one topic and more than one phase, but the phases had to be 154 
consecutive, as in the range 3-5, for instance. There were therefore more question-topic 155 
assignments and more question-phase assignments than there were questions.  156 
 Coding was performed by CEC (all crowdsourced questions), PK (half the crowdsourced 157 
questions), VMC (half the crowdsourced questions), and PC and RH (all clinic questions each). 158 
PK and RH are clinicians, VMC and PC healthcare researchers, and CEC a non-clinical 159 
bioinformatics researcher. For each question and topic, a score of 1 indicated that the question 160 
fell under that topic and a score of 0 that it did not. If both coders scored 1 or 0 for a question and 161 
topic, it was counted as agreement. Agreement for phase was determined by an overlap between 162 
one coder and the other. Intercoder reliability was computed using Cohen’s kappa with the 163 
following guidelines from [68]: slight agreement (0-0.2); fair (0.21 – 0.4); moderate (0.41 - 0.6); 164 
substantial (0.61 – 0.8); almost perfect (0.81 – 1). Disagreement between coders was resolved 165 
through consensus review by the coders and members of the project team.  166 
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Statistical analysis  167 
The following analyses were performed for topics and stratified by sex for the crowdsourced 168 
questions. The significance threshold was set at .05 except where indicated.  169 
 Because consecutive questions are more likely to stem from the same questioner in each 170 
corpus, the samples cannot be assumed to be independent. We therefore determined which, if 171 
any, individuals had highly correlated questions in terms of their topic assignments using the 172 
Pearson correlation coefficient. Then, following the guideline that multicollinearity may be a 173 
problem in a data set if any pairwise |r| > 0.7 [69], we removed the questions from any individual 174 
who had strongly correlated questions (|r| > 0.7 for any pair of his/her questions).  For each 175 
corpus, we  also examined all pairwise correlations between topics, in terms of the questions 176 
assigned to them, removing those topics, if any, that were strongly correlated. 177 
To determine which topics, if any, were significant predictors of a question’s coming 178 
from a patient in the clinic or from the public through crowdsourcing, we used Lasso regression 179 
with the Least Angle Regression (LARS) algorithm [70,71], Lasso-LARS is a model selection 180 
algorithm that uses repeated internal cross-validation to select variables and estimate coefficients 181 
in the presence of collinearity. We applied Lasso-LARS both before and after removal of highly 182 
correlated questions and topics. Computations were performed using the LassoLarsCV function 183 
from the scikit-learn python package with 10-fold cross validation and default parameters [72]. 184 
Lasso-LARS regression was also performed on the crowdsourced questions to determine which, 185 
if any, topics were significant predictors of a question’s coming from a woman or a man. 186 
We also examined each topic individually to determine if it was assigned significantly 187 
more often to the clinic or the crowdsourced questions, correcting for multiple comparisons 188 
using the Benjamini–Hochberg false discovery rate (FDR) [73-75].   For the crowdsourced 189 
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questions only, we similarly asked for each topic if it was assigned significantly more often to 190 
the questions asked by men or those asked by women. The 2-tailed z-test provided 95% 191 
confidence intervals (CI) for these estimates. This analysis told us something about the topics, in 192 
contrast to the Lasso-LARS analysis that told us something about the questions and the people 193 
asking them. The z-tests were performed after confirmation that the distribution of questions 194 
over topics was approximately normal. That is, we confirmed that the number of questions per 195 
topic was approximately normally distributed for both the crowdsourced and clinic questions 196 
under the Shapiro-Wilk test, both before and after removal of the correlated questions, and 197 
similarly for the female and male questions [76]. For the phases of disease progression, a similar 198 
analysis was done to determine which phases, if any, were assigned significantly more often to 199 
the clinic or the crowdsourced questions. 200 
To gain additional understanding of the differences between the clinic and crowdsourced 201 
questions, the top three (85th percentile) and top five (75% percentile) topics in terms of the 202 
number of questions to which they were assigned were identified for each corpus. Those that 203 
were top in one corpus and not the other were recognized as characteristic of that corpus. A 204 
similar analysis was done for the phases of disease progression. 205 
 206 
Descriptive analysis  207 
In addition to topic analysis and the analysis by phase of disease progression, the combined 208 
corpus of questions was reviewed from a holistic and descriptive perspective to ascertain any 209 
inferences implicit in the questions that might reveal underlying concerns or issues for the person 210 
generating the question.  It was apparent that the questioners, not all of whom had diabetes, were 211 
seeking more than just factual information. A limited qualitative analysis of the combined corpus 212 
 10 
 
was therefore undertaken to address this need for a broader interpretation of the questions beyond 213 
their literal content. This analysis was not exhaustive but illustrative, identifying themes that 214 
might inform a detailed analysis of a larger collection of questions.   215 
 216 
Results 217 
The topics  218 
A preliminary categorization of the crowdsourced questions using a core set of categories 219 
derived from earlier work [5-10, 16,55-57] produced a Cohen’s kappa score of 0.61 overall, 220 
which represents moderate to substantial agreement [68]. A subsequent round-table discussion by 221 
members of the project team (CEC, PK, VMC, MFM, ES, JGW and PC) led to the formulation of 222 
the 23 categories described in Table 1. Several diabetes-specific categories, namely LIFESTYLE / 223 
BEHAVIOR CHANGE (hereafter abbreviated simply to LIFESTYLE), EXERCISE, DIET, WEIGHT, and 224 
CURE OR REVERSAL, were added to the core categories. For this last topic, we note that a more 225 
clinically oriented topic descriptor would be CONTROL OR REMISSION. However, our experience to 226 
date with patient and general-public questions is that the lay perception centers on the idea of 227 
completely getting rid of a disease and for this reason we use the descriptor CURE OR REVERSAL.  228 
The topic of COMPLICATIONS derived from earlier work was split into DISEASE COMPLICATIONS 229 
and TREATMENT COMPLICATIONS to properly represent the types of questions found for T2DM. 230 
 231 
Table 1. Topic Categories for T2DM Questions. 232 
 233 
CAUSES Questions about the causes of diabetes or one of its complications. Includes 
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causal factors that might increase risk and causes of symptoms. 
RISK FACTORS 
Questions about factors that raise the risk of developing diabetes or any of its 
complications (not necessarily causal factors, for example, gender). 
PREVENTION 
Questions about the prevention of diabetes or the prevention of complications 
arising from diabetes. 
DIAGNOSIS 
Questions about diagnostic tests for diabetes or any of its complications. 
Includes questions about signs or symptoms that might lead to a diagnosis. 
Includes methods for determining the difference between pre-diabetes, type 1 
and type 2. 
MANIFESTATIONS Questions about signs or symptoms of diabetes or any of its complications. 
TREATMENT  
Questions about treatments for diabetes. Includes medication and self-
management behaviors that could be part of a treatment plan. 
ANATOMY 
Questions that make reference to any particular part of the body, such as 
questions about a location affected by diabetes. 
CURE / REVERSAL  
Questions about a cure for diabetes or about the reversal of symptoms to the 
point where one could be considered condition free or in remission. 
DIET / NUTRITION 
Questions about the role of diet or nutrition in the prevention, development or 
management of diabetes and its complications. 
EXERCISE 
Questions about the role of exercise in the prevention, development or 
management of diabetes and its complications. 
WEIGHT 
Questions about the role of weight in the prevention, development or 
management of diabetes and its complications. 
LIFESTYLE  
Questions about things a person can or must do to prevent or manage diabetes 
or its complications (including diet, exercise, or weight). 
DISEASE 
COMPLICATIONS 
Questions about the problems diabetes causes. This includes the risks faced 
by patients with diabetes and the nature and experience of the complications. 
TREATMENT 
COMPLICATIONS 
Questions about problems arising from specific treatments for diabetes or one 
of its complications. 
PERSON OR 
ORGANIZATIONS 
Questions about a person or organization involved with a disease. This can 
include medical specialists, hospitals, research teams, insurance payments, or 
support groups for a particular disease.  
PROGNOSIS 
Questions asking about life expectancy, quality of life, or the probability of 
success of a given treatment. 
DISTRIBUTION OF A 
DISEASE IN A 
POPULATION 
Questions about the occurrence of diabetes in a population and questions 
about the distribution of complications in the population of people with 
diabetes. 
INHERITANCE 
PATTERNS 
Questions about inheritance patterns in diabetes. 
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TRANSMISSION 
PATTERNS 
Questions about transmission patterns for diabetes (when conceived of as an 
infectious disease). 
RESEARCH Questions about research on diabetes. Includes questions about clinical trials. 
PSYCHOSOCIAL Questions about the social-emotional ramifications of diabetes. 
OWN HEALTH 
RECORD RELATED 
Questions that relate specifically to the questioner’s own health or that 
reference information in the person’s health record. Includes questions about 
“my” medication, etc. 
OTHER 
Questions that do not belong to any of the above. Includes non-medical 
questions about a disease, such as policy decisions, for example. 
 234 
 235 
The questions  236 
One hundred and sixty-four questions were collected from 120 patients during 12 outpatient 237 
clinics. Most of the questions were about diabetes (N=155) with the remainder related to clinic 238 
operation (N=9).  Of the questions on diabetes, 152 from 101 patients were about T2DM and 239 
these questions were retained for our analysis.  Although only 1 to 2 questions were asked for, 2 240 
patients gave 3 questions each.  Most of the patients attending the clinic had T2DM (95%).  241 
These questions are given in S1 File. 242 
 For the crowdsourced questions, 100 AMT participants each contributed three questions 243 
about diabetes (N=300). Most of the questions were about T2DM (N=284) with a smaller 244 
number related to type 1 diabetes (N=15) and 1 question duplicated by one of the questioners. Of 245 
the 100 questioners (F 34, M 66), 9 had diabetes (6 type 2, 2 type 1, one unknown type) and 91 a 246 
friend or family member with diabetes (30 type 2, 17 type 1, 44 unknown type). The 284 247 
questions about T2DM were retained for analysis. These questions are given in S2 File . For the 248 
clinic questions overall, agreement between the coders was substantial (Cohen’s kappa=0.77, SD 249 
= 0.18). For the crowdsourced questions overall, agreement between the coders was almost 250 
perfect (Cohen’s kappa = 0.86 SD = 0.1). Disagreements were resolved by consensus between 251 
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the coders.  252 
We found that for the crowdsourced questions, 16 of the 100 individuals had strongly 253 
correlated questions (|r| > 0.7 for any pair of their 2 or 3 questions) and, for the clinic questions, 254 
3 of the 101 patients. After removing the questions from the identified individuals there were 236 255 
crowdsourced questions from 84 individuals and 147 clinic questions from 98 patients 256 
remaining. We did not find the topics in the crowdsourced questions to be correlated at the 0.7 257 
criterion value, but for the clinic questions, TRANSMISSION PATTERNS was correlated with 258 
INHERITANCE PATTERNS at the 0.7 level. We therefore dropped the category TRANSMISSION 259 
PATTERNS, which had only 2 questions in the crowdsourced corpus and 5 in the clinic corpus, all 260 
of which also fell under other topic categories and consequently did not need to be removed.  261 
Topics and the clinic and crowdsourced questions  262 
The clinic questions had an average of 2.8 topics per question (min 1, max 7) and the 263 
crowdsourced questions had an average of 2.1 topics per question (min 1, max 5). The results of 264 
the Lasso-LARS regression on all questions showed slightly higher odds ratios in favor of 265 
questions that were OWN HEALTH RECORD RELATED and about TREATMENT coming from the 266 
clinic patients (1.143 and 1.114 respectively). The odds ratios for all other questions were less 267 
than 1.062. The optimum alpha value found was 0.0009 with a mean squared error of 0.151 for 268 
both the training and test data. Lasso-LARS regression on only the non-correlated questions 269 
revealed similar slightly higher odds ratios in favor of the clinic questions for the same two 270 
topics (1.173 and 1.156 for OWN HEALTH RECORD RELATED and TREATMENT, respectively), with 271 
all other odds ratios less than 1.1. The optimum alpha value was 0.0006 with a mean squared 272 
error for the training data of 0.132 and 0.187 for the test data.  273 
In terms of the individual topics, topics that were assigned significantly more often to the 274 
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crowdsourced than the clinic questions were CAUSES (CI: [-0.07, -0.03], p < .001), RISK 275 
FACTORS ([-0.08, -0.03], p < .001), PREVENTION ([-0.06, -0.02], p < .001), DIAGNOSIS ([-0.05, -276 
0.02], p < .001), and DISTRIBUTION OF A DISEASE IN A POPULATION ([-0.05 ,-0.01], p = .0016). In 277 
contrast, the topics TREATMENT ([0.03, 0.01], p = .0019), DISEASE COMPLICATIONS ([0.02, 0.07], 278 
p < .001), and PSYCHOSOCIAL ([0.05, 0.1], p < .001) were assigned significantly more often to the 279 
clinic questions. See Table 2. 280 
 281 
Table 2. Topics Assigned to the Crowdsourced and Clinic Questions. 282 
 283 
 Crowdsourced  
(N=236) 
Clinic 
(N=147) 
CI* FDR-
adjusted p-
values, 2-
tailed z-test 
Causes 49 / 675** 14 / 598** (-0.07, -0.03) < .001 
Risk Factors 64 / 675 23 / 598 (-0.08, -0.03) < .001 
Prevention 33 / 675 7 / 598 (-0.06, -0.02) < .001 
Diagnosis 31 / 675 6 / 598 (-0.05, -0.02) < .001 
Manifestations 45 / 675 43/ 598 (-0.02, 0.03) .747 
Treatment 61 / 675 91 / 598 (0.03, 0.01) .0019 
Anatomy 20 / 675 29 / 598 (-0.0, 0.04) .1383 
Cure / Reversal  47 / 675 28 / 598 (-0.05, 0.0) .1383 
Diet / Nutrition 8 / 675 5 / 598 (-0.01, 0.01) .6942 
Exercise 12 / 675 9 / 598 (-0.02, 0.01) .747 
Weight 65 / 675 56 / 598 (-0.03, 0.03) .8721 
Lifestyle  33 / 675 43 / 598 (-0.0, 0.05) .1383 
Disease Complications 16 / 675 40 / 598 (0.02, 0.07) < .001 
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Treatment Complications 7 / 675 16 / 598 (0.0, 0.03) .0696 
Person or Organization 41 / 675 41 / 598 (-0.02, 0.03) .6973 
Prognosis 18 / 675 7 / 598 (-0.03, -0.0) .1207 
Distribution of a Disease 
in a Population 
26 / 675 5 / 598 (-0.05, -0.01) .0016 
Inheritance Patterns 15 / 675 20 / 598 (-0.01, 0.03) .3251 
Research 20 / 675 20 / 598 (-0.02, 0.02) .747 
Psychosocial 4 / 675 47 / 598 (0.05, 0.1) < .001 
Own Health Record 
Related 
27 / 675 30 / 598 (-0.01, 0.03) .5244 
*Confidence intervals at the .05 level 284 
**The denominator in each column is the number of topic assignments in total for the corpus. 285 
  286 
 The three most frequent clinic topics (Table 2) were TREATMENT (91 questions), WEIGHT 287 
(56) and PSYCHOSOCIAL (47).  The three most frequent crowdsourced topics also included 288 
WEIGHT (65) and TREATMENT (61), but included RISK (64) rather than PSYCHOSOCIAL. The topic 289 
PSYCHOSOCIAL therefore characterizes the clinic questions and the topic RISK FACTORS the 290 
crowdsourced questions. The next two clinic topics were MANIFESTATIONS (43) and LIFESTYLE 291 
(43), which were not in the top crowdsourced topics, and therefore further characterize the clinic 292 
questions. The next two crowdsourced topics were CAUSES (49) and CURE / REVERSAL (47), 293 
which were not in the top clinic questions, and therefore further characterize the crowdsourced 294 
questions.  295 
For the crowdsourced questions, Lasso-LARS regression showed a slightly higher odds 296 
ratio (1.122) for a question about WEIGHT coming from a woman rather than a man.  The 297 
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optimum alpha value found was 0.0024 and the mean squared error for the training data was 298 
0.193 and 0.235 for the test data.  299 
In terms of the individual topics, the only topic that was more strongly associated with 300 
one gender over another was PSYCHOSOCIAL (CI: [0.02, 0.05], p = .1497), which was more 301 
strongly represented in the male questions, but only at the 0.2 level.  For both men and women, 302 
the topics LIFESTYLE (women 24 questions; men 41 questions), RISK FACTORS (24; 41), and DIET 303 
(19; 28) were most frequently assigned. There was one topic appearing uniquely in the top five 304 
for men and one for women that might in addition be thought of as characterizing the two 305 
groups. These were MANIFESTATIONS (women 18 question) and PROGNOSIS (men 24 questions).  306 
The phases of disease progression 307 
The five phases of T2DM progression we identified from the literature and our experience 308 
were:  PRIOR TO ANY DIAGNOSIS; PRE-DIABETIC (DIAGNOSED); ONSET OF T2DM; HEALTH 309 
MAINTENANCE AND PREVENTION; COMPLICATIONS – MINOR (ONSET) OR MAJOR 310 
(DOMINANCE). These are listed in Table 3 along with a description of each phase.  311 
 312 
Table 3. Phases of Disease Progression for T2DM. 313 
 
PHASE 1 
PRIOR TO ANY 
DIAGNOSIS 
Given that 27.8% (8.1 million) of those estimated to have diabetes 
in the USA are undiagnosed, it is important to understand the 
questions people may have prior to a diagnosis. Given the 
increasing prevalence of T2DM, many people have family 
members or friends with a diagnosis. Questions may therefore not 
be about their own susceptibility but about giving support to 
others with the condition. 
PHASE 2 PRE-DIABETIC 
(DIAGNOSED) 
On being diagnosed as pre-diabetic, a person’s questions may 
reveal a response of confusion, denial or fear. In coming to terms 
with the fact that s/he may be facing a serious chronic illness, the 
person may have questions about the choices s/he has to make. 
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PHASE 3 ONSET OF T2DM 
With the onset of T2DM, questions may reveal a response of 
anger or denial or a wait-and-see attitude. In accepting that s/he 
has to live with a serious chronic illness, the person may have 
questions about new knowledge that must be acquired and a new 
and possibly demanding self-care regimen that must be adjusted 
to. If the onset of diabetes is abrupt, the adjustment may be 
particularly difficult and questions may reflect this struggle. 
PHASE 4 
HEALTH 
MAINTENANCE 
AND PREVENTION 
After initial diagnosis, questions may reveal a person energized 
to manage his/her diabetes. A lack of questions may indicate a 
person trying to ignore his/her diabetes. As treatment focuses on 
the prevention of diabetes complications, questions may focus on 
the new self-care behaviors that must be maintained. 
PHASE 5 
COMPLICATIONS – 
MINOR (ONSET) 
OR MAJOR 
(DOMINANCE) 
With the onset of complications, a person may be energized by 
the complications to manage his/her diabetes. Or s/he may 
respond with fatalism or increased distress. Questions may 
reflect attempts to understand and accept a new condition 
trajectory. Questions may focus on maximizing quality of life, 
especially as complications come to dominate the person’s life. 
Questions may seek emotional support, not just knowledge, as 
the person’s self-image as a functioning, healthy adult undergoes 
possible change.  The person must learn to live with challenges 
that may affect his/her activity levels, functional abilities, and 
emotional and social well-being. As the person’s condition 
progresses, new questions will arise. 
 314 
 315 
 For both the clinic and consumer questions, intercoder reliability for categorization by 316 
phase was moderate (k = 0.64 clinic; k =0.67 crowdsourced). Given the exploratory nature of this 317 
categorization by phase, by consensus the coders agreed to assign a phase category to a question 318 
if either one of the coders did so. In this way, the judgements of all coders (clinical and non-319 
clinical) could be taken into account.  320 
Phases and the clinic and crowdsourced questions 321 
There were significantly more crowdsourced questions that concerned Phase 1, the time PRIOR 322 
TO ANY DIAGNOSIS (CI: [-0.11, -0.04], p = .0013), and significantly more clinic questions about 323 
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Phase 4, HEALTH MAINTENANCE AND PREVENTION (CI: [0.07. 0.17], p < .001). See Table 4.  324 
 325 
Table 4. Phases Assigned to the Crowdsourced and Clinic Questions. 326 
 327 
 Crowdsourced  
(N=236) 
Clinic 
(N=147) 
CI* FDR-
adjusted p-
values, 2-
tailed z-test  
Phase 1: Prior to any 
Diagnosis 
118 / 756** 32 / 386** (-0.11, -0.04) .0013 
Phase 2: Pre-diabetic 
(diagnosed) 
127 / 756 49 / 386 (-0.08, 0.0) .0692 
Phase 3: Onset of T2DM 
220 / 756 91 / 386 (-0.11, -0.0) .0647 
Phase 4: Health Maintenance 
and Prevention 
148 / 756 122 / 386 (0.07, 0.17) < .001 
Phase 5: Complications – 
Minor (onset) or Major 
(dominance) 
143 / 675 92 / 386 (-0.0, 0.1) .0647 
*Confidence intervals at the .05 level  328 
**The denominator in each column is the number of phase assignments in total for the corpus. 329 
 330 
 The most frequently applied phase in the clinic questions was Phase 4 (HEALTH 331 
MAINTENANCE AND PREVENTION, 122 questions). This was followed by Phases 5 and 3, then 332 
Phases 2 and 1. The most frequently applied phase in the crowdsourced questions was Phase 3 333 
(ONSET OF T2DM, 220 questions) followed by Phases 4 and 5, then Phases 2 and 1. Phase 334 
assignment numbers for clinic and crowdsourced questions are shown in Fig 1.  335 
 336 
Fig 1. Clinic and Crowdsourced Questions by Phase.  337 
 338 
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Descriptive analysis  339 
Our descriptive analysis identified four themes to pursue in future studies: (1) the specificity 340 
found in questions; (2) questions revealing the emotion behind an information need; (3) 341 
questions disclosing information needs not yet recognized in standard patient information 342 
resources; and (4) the potential for questions to identify specific constituent groups with their 343 
own information needs. 344 
(1) The specificity of questions 345 
Questions encourage specificity. The topic “diabetes and prognosis,” for instance, does not 346 
capture the specificity of the following four prognosis-related questions taken from our corpora: 347 
 Is diabetes a death sentence? 348 
 Will all Type 2 eventually go on to insulin?  349 
 Is there any potential for a cure within the next few years, according to current research? 350 
The first concerns a worst outcome, the second the inevitability of a treatment, and the third a 351 
best outcome. Numerous questions contemplated a decline in health, for example: 352 
 Will it get worse [?]  353 
 Will my condition only worsen [?] 354 
Many asked about the likelihood and hoped-for outcome of specific treatments, for example: 355 
 Can I ever reduce insulin & meds and feel good [?]  356 
 Can diabetes be cured or rendered almost gone overtime through medicine and nutrition 357 
[?] 358 
 Could a pancreas transplant cure diabetes in a person? 359 
 What dictates the type of treatment needed/required for diabetes, and is directly injecting 360 
insulin ever avoidable? 361 
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Prognosis questions that were about a possible cure for diabetes were prominent. See S1 Table. 362 
All questions contained the word “cure,” or similar, such as “reverse,” “heal,” “[fully] go away,” 363 
“[completely] get over.” Many questions looked to scientific research for a cure and 364 
acknowledged it as a matter for the future. A smaller number specifically referred to diet or 365 
lifestyle changes, something an individual can do to affect the course of diabetes. Those asking 366 
such questions may be more receptive to taking action on their own behalf. 367 
(2) Questions revealing the emotion behind an information need 368 
Consider the following two questions, both ostensibly seeking to understand why the questioner 369 
has diabetes. 370 
 How on earth I ever got diabetes in the first place. Never over weight blood pressure 371 
always fine never eat sweet food [?] 372 
 Why me? 373 
The first question shows some understanding of risk factors for the condition without, it seems, 374 
fully understanding genetic risks. Puzzlement and frustration are expressed. The second question 375 
is less a plea for information and more an expression of frustration and defeat. Its meaning, and 376 
what counts as an adequate answer, will differ depending on when it is asked – at diagnosis, at a 377 
periodic review of the patient’s care, when a new complicating factor has arisen that will affect 378 
self-management, or when there is a transition in care, such as with age-related changes or a 379 
change in the care team [77].  380 
(3) Questions disclosing as yet unrecognized information needs 381 
It is crucial that information on diabetes covers not only what health professionals consider 382 
important for people to know but also what the different constituent groups want to know, 383 
whether considered important to health professionals or not. Directly solicited, open-ended 384 
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invitations to ask questions are a way to reveal information needs that may not be anticipated by 385 
health educators. Take the following questions that in effect ask for a severity index for diabetes.  386 
 Are there variations in severity to diabetes and what determines severity? 387 
 To what extent does it exist on a spectrum, such that people may be classified according 388 
to the degree to which they are diabetic, even if they are not diagnosable as diabetic 389 
according to present criteria? 390 
 Are there variations in severity to diabetes and what determines severity? 391 
This topic is covered in the literature [78] but not prominently or not at all in the trusted and 392 
vetted sources of patient-oriented diabetes information resources. It may be important to some 393 
patients’ needs to fully understand their condition. A related set of questions reveals a similar and 394 
important wish, whether feasible or not, to be able to monitor one’s health before it gets to a 395 
point of no return [79], as explicitly stated in this question: 396 
 If you suspect you have Type 2 diabetes, at which point will it become impossible for you 397 
to reverse it by only changing your diet and exercise habits (and without requiring 398 
medication or the need to see a doctor?) 399 
(4) Questions from specific constituent groups 400 
Diabetes information is important not only for people with diabetes but also friends and family of 401 
people diagnosed with diabetes and for caregivers, those family members, neighbors, friends or 402 
paid persons who regularly look after someone with diabetes. Our corpora included several such 403 
questions.   404 
 What are some ways to help a family member accept a diagnosis of diabetes? 405 
 How hard is it to treat when the person who needs help isn't very receptive to their 406 
condition? 407 
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 What are some things you can do to help a family member better manage an appropriate 408 
diet for type 2 diabetes? 409 
 What is the best way I can help my friends and family members with controlling their 410 
diabetes? 411 
For other chronic conditions such as mental-health disorders, for instance, the role of family and 412 
friends is broadly acknowledged and discussed in education and information resources. Question 413 
collection on a massive scale may suggest a more prominent place for this topic in diabetes 414 
education. 415 
 416 
Discussion 417 
Principal results  418 
The topics associated with the clinic questions (OWN HEALTH RECORD RELATED, DISEASE 419 
COMPLICATIONS, TREATMENT, and PSYCHOSOCIAL) confirm what might be expected, namely that 420 
patients whose condition is actively being managed are most concerned about complications of 421 
the condition specific to their medical history, with a primary concern being about psychosocial 422 
matters related to their disease. T2DM is a complex condition that has different disease 423 
progressions for different people and for the same person over time and as life circumstances 424 
change [69]. Significant effort has to go into making sense of the experience. A recent study 425 
comparing people seeking online health information for their own problem against those seeking 426 
information for someone else’s showed that the first group in contrast to the second focused 427 
primarily on symptoms and matters related to their own disease history [80].  428 
The crowdsourced questions’ focus on CAUSES, RISK FACTORS. PREVENTION, DIAGNOSIS, 429 
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and DISTRIBUTION OF A DISEASE IN A POPULATION most likely reflects the fact that the 430 
crowdsourced questioners were in the main (91%) not themselves diagnosed but knew someone 431 
who was and so likely sought to understand what leads to diabetes and who among their family 432 
members may be at risk. Those seeking online information for someone else’s health problem 433 
have been shown to focus primarily on causes of a disease and disease terminology [80].  434 
The stronger representation of PSYCHOSOCIAL questions from men warrants further 435 
investigation. Gender-based notions of masculinity have been shown for some people to be in 436 
conflict with effective self-management of T2DM, a central component in the treatment of 437 
diabetes [81]. The stronger representation of questions on WEIGHT from women is perhaps not 438 
unexpected, but with recent research showing that men are developing T2DM at lower levels of 439 
adiposity than women, this may change [82]. 440 
 The clinic questions, not surprisingly, predominantly concerned post-diagnosis issues 441 
whereas the onset of diabetes dominated crowdsourced questions. The number of crowdsourced 442 
questions asking, in effect, how you know if you have diabetes accounts for the high number of 443 
questions categorized under Onset of T2DM. Such a concern is consistent with the fact that over 444 
30 percent of those with diabetes in the United States are unaware they have the disease [13]. It 445 
also perhaps indicates that the public health message about the prevalence of diabetes is being 446 
heard and people are wondering about their own health status.   447 
Related studies 448 
There is a long and extensive record of questions being collected from health professionals and 449 
analyzed. Questions have been collected at the point of care, from email consultation with 450 
specialists, and through queries to information systems [26, 31, 33, 35-38]. Clinical questions 451 
have been categorized as to the kind of knowledge they sought and the kind of answers they 452 
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needed, with taxonomic and other organizing structures proposed for them [24, 27, 35, 37]. The 453 
questions of family-medicine, elder-care, and rural-health physicians have been explored [25, 29, 454 
30, 32, 34, 44]. Experiments have been done on different ways of capturing clinical questions 455 
through voice and other input media [28, 39-43]. Clinical questions associated with specific 456 
disorders have been evaluated, most notably cancer [42], and T2DM [31]. A systematic review 457 
of three decades of studies on clinical information needs [30] found that roughly 30% of the 458 
question types accounted for 80% of the questions clinicians asked, where a question’s type was 459 
relative to a 64-item taxonomy [24].  460 
Studies of questions from healthcare consumers are relatively recent. In [45], 276 health-461 
related questions posted on a social media question-answer website were subjected to qualitative 462 
content analysis, focusing on meta-characteristics of the questions such as the users’ motivations 463 
for asking the questions. In [46] and  [47] a manual topic-based analyses of consumer questions 464 
was done using topics from the UMLS. In [49], 365 questions from a mailing list were analyzed 465 
in terms of topics and the type of question. In [50] and [51] smaller question collections (72 and 466 
12) were subjected to detailed semantic, attitudinal or linguistic analysis. An increasing number 467 
of studies concern the development of question–answering technology for consumer health 468 
questions [83-87].Patients have different information needs about T2DM at different points as 469 
their disease progresses.  However little is known about these needs and how they change over 470 
time or across varying health or life circumstances [77] — even though there has been a 471 
significant amount of research on what the different phases of T2DM are [58-67]. It is in cancer 472 
care that the needs of patients at different stages of their disease have been most thoroughly 473 
studied [88-9091]. These studies, show, for instance, that while most (91%) female breast-cancer 474 
patients wanted to know their prognosis before beginning adjuvant treatment [91], after the first 475 
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consultation, their needs often shifted to matters of support, with 59-63% primarily wanting 476 
reassurance and hope and patients with advanced disease often desiring less information about 477 
their illness [88]. It is important that we develop a similar understanding of the changing needs 478 
of people with T2DM.  479 
Further research 480 
The urgent need for resources allowing patients with T2DM to find answers to their questions 481 
has recently been documented [52]. One longer-term goal of this study is to develop a question-482 
answer system, informed by the analysis of a very large number of questions and vetted answers 483 
and based on the automated identification of topics in questions. The twenty-three categories we 484 
devised for this study will almost certainly need further refinement, with a hierarchy of topics or 485 
an ontology possibly providing a better representation. In addition, answer topics as well as 486 
question topics need to be defined. For example, suppose a patient’s question is “I’m 44 and 487 
recently diagnosed with Type 2 diabetes, and now I am having difficulty reading fine print. Is 488 
this related to my diabetes?” This question falls into four possible answer categories. The first 489 
relates to temporary changes in eyesight when blood glucose fluctuates. The second concerns a 490 
side effect of the drug pioglitazone. The third is about diabetic retinopathy that leads to 491 
blindness. And the fourth concerns normal age-related changes in eyesight.  492 
 Finer-grained characteristics that are important in the management of diabetes are also 493 
needed.  For example, the capacity of a person to act in any given environment (known as 494 
agency) seems to be expressed differentially in our questions [92]. The following question about 495 
a cure for diabetes appears to locate agency within the patient: “What stuff do you have to do to 496 
cure diabetes?” This is in contrast to a question that appears to locate agency within the broader 497 
society: “How close is science to finding a cure for diabetes?”  If patients over time asked 498 
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questions that differed in the location of agency, that would be of interest and possible clinical 499 
significance. In our follow-up studies when new questions are collected from patients, we will be 500 
labeling each question by the stage the questioner is in relative to his or her own disease 501 
progression.  In this way a record of the questions asked in the aggregate by patients at each 502 
phase of the disease can be compiled along with the progression of questions for each patient 503 
individually, providing a broader and deeper perspective on the complex needs of those affected 504 
by or at risk of T2DM. 505 
 506 
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